April 26, 2026 5:18 PM
Latest:
  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness
  • Equinox Ups Its Offer For Calibre: Investors Said No!
  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash
  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win
  • Agnico Eagle Q1 Earnings: Costs Go Down?!
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Cannabis
    • Commentary
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Resources
    • Technology
  • Resources
  • Energy
  • Technology
  • Coverage Companies
    • Brazil Potash
    • Canadian Copper
    • Cardiol Therapeutics
    • Cytophage Technologies
    • ESGold Corp
    • First Majestic Silver
    • Golden Cariboo Resources
    • Nations Royalty Corp
    • Plurilock Security
    • Power Metallic
    • PTX Metals
    • Riverside Resources
    • Rua Gold
    • Silver47 Exploration
    • Sonoro Gold
    • Spirit Blockchain
    • Temas Resources
  • Verses AI
  • About
  • Contact Us

Psychedelics

Latest Psychedelics 

Field Trip Health To Divide Into Two Separate Firms

April 29, 2022 8:01 AMApril 29, 2022 8:01 AM Jay Lutz 0 Comments Field Trip Health, Reunion Neuroscience

Field Trip Health (TSX: FTRP) is set to be split into two separate firms. The company last night indicated that

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Mydecine Announces 50 To 1 Share Consolidation

April 14, 2022 8:14 AMApril 14, 2022 8:14 AM Jay Lutz 0 Comments Mydecine Innovations

Mydecine Innovations (NEO: MYCO) is the latest firm to announce a reverse stock split amid a recent trend amongst small

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Numinus Wellness To Acquire Novamind In All Stock Transaction At $0.44 Per Share

April 12, 2022 7:56 AMApril 12, 2022 7:56 AM Jay Lutz 0 Comments Novamind, Numinus Wellness Inc

Consolidation within the psychedelics space is getting underway, with the announcement this morning that Numinus Wellness (TSX: NUMI) will be

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Red Light Holland Acquires 100 Acres Of Land To Grow Mushrooms

April 11, 2022 9:09 AMApril 11, 2022 9:10 AM Jay Lutz 0 Comments Red Light Holland

Evidently there is big money within the mushroom market. Red Light Holland (CSE: TRIP) this morning indicated it is dropping

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Mind Medicine CFO Quits Ahead Of Release Of 2021 Financial Results

March 28, 2022 6:45 AMMarch 27, 2022 11:20 PM Jay Lutz 0 Comments Mind Medicine, MindMed

It’s always a positive sign when a chief financial officer resigns the last business day before annual filings are to

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Core One Labs Looks To Sell Out To Big Pharma As Capital Dries Up In Psychedelics Space

March 20, 2022 9:00 AMMarch 20, 2022 12:15 AM Jay Lutz 0 Comments Core One Labs Inc

Evidently there has been a shift of strategy behind the scenes at Core One Labs (CSE: COOL). The company late

Share
Tweet
Share
Reddit
Read more
Latest Psychedelics 

Mind Cure Gives Up On Psychedelics, Fires C-Suite, And Reverts To Shell After Strategic Review

March 16, 2022 11:58 AMMarch 16, 2022 10:51 AM Jay Lutz 0 Comments Mind Cure Health

In a sign of what’s to come for most psychedelic-related names, Mind Cure Health (CSE: MCUR) this morning effectively announced

Share
Tweet
Share
Reddit
Read more
Latest News Psychedelics 

Bright Minds Moves Into Clinical Development Stage Following Positive Toxicity Results

March 14, 2022 7:54 AMMarch 14, 2022 7:54 AM Jay Lutz 0 Comments Bright Minds Biosciences

Drug development continues for the Bright Minds Biosciences (CSE: DRUG) lead product. The firm this morning published positive results from

Share
Tweet
Share
Reddit
Read more
Healthcare Latest Psychedelics 

Mind Medicine Sees Final Co-Founder Leave The Company

January 9, 2022 3:07 PMJanuary 9, 2022 10:08 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) appears to now be fully under new management. On Friday evening, after the close of markets,

Share
Tweet
Share
Reddit
Read more
Biotech Latest Psychedelics 

MindMed Concludes Phase 1 Clinical Trial Of Psychedelic Derivative Drug For Opioid Use Disorder

January 4, 2022 10:29 AMJanuary 4, 2022 9:45 AM ER Velasco 0 Comments Mind Medicine, MindMed

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, has recently concluded the phase 1 clinical trial for its

Share
Tweet
Share
Reddit
Read more
  • ← Previous
  • Next →

Latest

  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness

  • Equinox Ups Its Offer For Calibre: Investors Said No!

  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash

  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win

  • Agnico Eagle Q1 Earnings: Costs Go Down?!

  • Why Gold Is Secretly Flooding Into The U.S. & Who’s Suppressing Silver?! | Andy Schectman

  • Gold @ $3500: All We Need Is $700 To Break Even! | Brad Kitchen – ESGOLD Corp.

  • Canada Is Nearly Last In Growth Among OECD Countries

Video

Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Full Analysis Latest Resources Video Series 

Teck Resources Q1 Earnings: Defying Copper Industry Weakness

April 27, 2025 4:40 PM Jay Lutz 0

Yesterday in our coverage of First Quantum Mining’s business we said it was a terrible time to be a copper

Trending

  • US Oil Storage Expected to Reach Full Capacity in Coming Months
  • The Golden Triangle: British Columbia’s Exploration Hotbed
  • Boosting Titanium Production Amid Heightened Reliance On Russia, China Supply
  • Missouri Cannabis Sales Rake in $240 Million in New Tax Revenue Over Past Year
  • BC Expedites 18 Resource Projects Representing $20B In Investment

News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
Biotech Latest News 

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek
Latest News Resources 

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0
Canadian Copper To Begin Exploration At Murray Brook East
Latest News Resources 

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Bonds
  • Cannabis
  • Commentary
  • Crypto
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2026 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.